Skip to main content
logo
CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
47.25
-2.79 (-5.58%)
Nov 10, 2026, 10:41 AM EST - Market open

CRISPR Therapeutics AG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Market Capitalization
4,5835,3495,3714,5664,9985,8944,2902,9193,3604,1594,5865,4724,9723,6044,6803,5573,1835,0984,7074,8385,799
Market Cap Growth (YoY)
-11.58%-9.25%25.20%56.43%48.76%41.74%-6.46%-46.65%-32.44%15.37%-1.99%53.82%56.24%-29.29%-0.58%-26.47%-45.12%-40.23%-63.71%-47.37%-46.39%
Enterprise Value
3,0873,7683,7172,7973,2644,3892,6541,2391,6512,3772,7134,0153,4742,0773,0301,9331,4523,2672,7252,6833,527
Last Close Price
50.0455.3254.5447.5752.4464.8148.6434.0339.3646.9854.0168.1662.6045.3956.1445.2340.6565.3560.7762.7775.78

Price Ratios

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
-------------32.37--------
PS Ratio
192.83212.50401.091112.851423.80153.76112.7677.4890.0320.5022.6820.1413.40-27.5135.482656.64361.78317.595.296.34
PB Ratio
2.943.253.082.522.603.082.511.601.742.142.322.632.642.092.581.921.702.612.252.152.42
P/TBV Ratio
2.953.253.082.522.603.082.511.601.742.142.322.632.642.092.581.921.702.612.252.152.42
P/FCF Ratio
------------32.85----9.45-----
P/OCF Ratio
------------34.32----10.11-----

EV Ratios

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
EV/Sales Ratio
133.37149.71277.57681.68930.04114.4869.7632.8844.2611.7213.4214.789.36-17.8219.281211.76231.82183.852.933.86
EV/EBITDA Ratio
-------------17.14--------
EV/EBIT Ratio
-------------15.61--------
EV/FCF Ratio
------------24.10----5.13-----

Financial Efficiency

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Debt / Equity Ratio
0.470.470.450.430.110.110.130.120.120.120.120.110.130.140.140.130.130.120.120.110.09
Debt / EBITDA Ratio
------------0.71--------
Debt / FCF Ratio
------------1.41----0.64-----
Net Debt / Equity Ratio
-0.91-0.91-0.90-0.91-0.92-0.90-0.88-0.89-0.87-0.88-0.90-0.90-0.77-0.87-0.84-0.89-0.87-0.89-0.88-0.88-0.90
Net Debt / EBITDA Ratio
3.003.003.083.123.223.773.443.593.765.465.326.717.193.723.373.062.502.613.01-5.95-5.50
Net Debt / FCF Ratio
3.973.974.264.125.115.724.635.3111.618.9314.1311.255.405.124.224.383.053.403.55-4.78-4.71
Asset Turnover
0.010.010.010.000.000.020.020.020.020.090.090.120.170.080.070.0400.010.010.400.40
Quick Ratio
16.1216.1217.7917.9213.2516.1016.4915.5321.9721.5515.6617.7217.4715.6413.8412.8315.0812.5717.2219.5419.92
Current Ratio
16.2116.2117.8517.9713.3216.2216.6115.6422.0721.6415.7317.8117.5415.8314.0013.0015.3012.8117.5719.8820.17
Return on Equity (ROE)
-25.60%-25.60%-26.10%-31.21%-30.18%-25.33%-25.34%-19.71%-19.20%-13.07%-14.00%-11.03%-8.17%-19.20%-21.29%-25.56%-30.42%-30.48%-26.99%15.39%18.59%
Return on Assets (ROA)
-13.49%-13.49%-14.20%-14.06%-15.76%-13.28%-13.05%-12.88%-13.04%-9.57%-9.77%-7.97%-6.22%-11.93%-12.70%-14.47%-16.85%-16.60%-14.77%8.55%10.20%
Return on Invested Capital (ROIC)
-322.56%-282.66%-286.50%-311.13%-280.87%-215.94%-219.35%-234.87%-137.29%-144.25%-140.89%-141.38%-60.86%-159.97%-168.85%-236.68%-244.99%-254.06%-267.72%117.26%150.55%
Return on Capital Employed (ROCE)
-21.50%-21.50%-21.10%-21.20%-26.90%-22.50%-23.70%-23.20%-21.70%-15.30%-16.00%-12.90%-10.50%-21.40%-22.90%-26.80%-31.70%-31.20%-27.00%12.50%14.20%

Yields

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Earnings Yield
-10.05%-8.53%-8.40%-12.45%-11.64%-8.28%-10.90%-13.21%-10.90%-5.76%-5.79%-3.97%-3.09%-9.81%-8.89%-14.73%-20.43%-13.36%-13.46%6.44%6.51%
FCF Yield
-7.76%-7.04%-6.91%-8.79%-6.92%-5.14%-7.59%-10.55%-4.31%-4.60%-2.75%-3.04%-5.43%-8.12%-7.73%-10.59%-16.74%-9.98%-10.96%8.57%7.89%
Buyback Yield / Dilution
-9.95%-5.95%-10.85%-11.77%-11.47%-7.12%-2.53%-5.07%-5.09%-7.33%-7.37%-3.96%-3.82%-1.79%-2.04%-2.05%-2.20%-2.27%3.65%-2.79%-7.53%
SEC Filings: 10-K · 10-Q